Andrew Spaventa
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
12 Feb 2025 |
1,907 |
22,873
|
-
|
|
-
|
Restricted Stock Units |
Andrew Spaventa
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
12 Feb 2025 |
1,907 |
2,232
|
-
|
|
-
|
Common Stock |
Andrew Spaventa
|
Director, Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
12 Feb 2025 |
1,107 |
142,900
|
-
|
|
0
|
Common Stock |
Andrew Spaventa
|
Director, Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
12 Feb 2025 |
1,107 |
325
|
-
|
|
0
|
Common Stock |
Andrew Spaventa
|
Director, Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 19.89 per share. |
12 Feb 2025 |
800 |
1,432
|
-
|
19.9 |
15,912
|
Common Stock |
Eli Glezer
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Feb 2025 |
500 |
155,583
|
-
|
|
-
|
Common Stock |
Eli Glezer
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Feb 2025 |
500 |
6,000
|
-
|
|
-
|
Restricted Stock Units |
Dalen Meeter
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Feb 2025 |
500 |
9,502
|
-
|
|
-
|
Common Stock |
Dalen Meeter
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Feb 2025 |
500 |
6,000
|
-
|
|
-
|
Restricted Stock Units |
Jyotsna Ghai
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Feb 2025 |
250 |
3,283
|
-
|
|
-
|
Common Stock |
Jyotsna Ghai
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Feb 2025 |
250 |
3,000
|
-
|
|
-
|
Restricted Stock Units |
Jyotsna Ghai
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
02 Jan 2025 |
417 |
3,033
|
-
|
|
-
|
Common Stock |
Jyotsna Ghai
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
02 Jan 2025 |
417 |
4,583
|
-
|
|
-
|
Restricted Stock Units |
Andrew Spaventa
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Dec 2024 |
486 |
811
|
-
|
|
-
|
Common Stock |
Andrew Spaventa
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Dec 2024 |
486 |
4,374
|
-
|
|
-
|
Restricted Stock Units |
Andrew Spaventa
|
Director, Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
15 Dec 2024 |
306 |
141,793
|
-
|
|
0
|
Common Stock |
Andrew Spaventa
|
Director, Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
15 Dec 2024 |
306 |
325
|
-
|
|
0
|
Common Stock |
Andrew Spaventa
|
Director, Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 20.16 per share. |
15 Dec 2024 |
180 |
631
|
-
|
20.2 |
3,629
|
Common Stock |
Eli Glezer
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Dec 2024 |
250 |
2,250
|
-
|
|
-
|
Restricted Stock Units |
Eli Glezer
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Dec 2024 |
250 |
155,083
|
-
|
|
-
|
Common Stock |
Dalen Meeter
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Dec 2024 |
209 |
9,002
|
-
|
|
-
|
Common Stock |
Dalen Meeter
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Dec 2024 |
209 |
1,874
|
-
|
|
-
|
Restricted Stock Units |
Andrew Spaventa
|
Director, Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
12 Nov 2024 |
1,212 |
325
|
-
|
|
0
|
Common Stock |
Andrew Spaventa
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
12 Nov 2024 |
1,907 |
2,232
|
-
|
|
-
|
Common Stock |
Andrew Spaventa
|
Director, Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 22.55 per share. |
12 Nov 2024 |
695 |
1,537
|
-
|
22.5 |
15,669
|
Common Stock |
Andrew Spaventa
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
12 Nov 2024 |
1,907 |
24,780
|
-
|
|
-
|
Restricted Stock Units |
Andrew Spaventa
|
Director, Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
12 Nov 2024 |
1,212 |
141,487
|
-
|
|
0
|
Common Stock |
Eli Glezer
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Nov 2024 |
500 |
6,500
|
-
|
|
-
|
Restricted Stock Units |
Eli Glezer
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Nov 2024 |
500 |
154,833
|
-
|
|
-
|
Common Stock |
Dalen Meeter
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Nov 2024 |
500 |
6,500
|
-
|
|
-
|
Restricted Stock Units |
Dalen Meeter
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Nov 2024 |
500 |
8,693
|
-
|
|
-
|
Common Stock |
Jyotsna Ghai
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Nov 2024 |
250 |
3,250
|
-
|
|
-
|
Restricted Stock Units |
Jyotsna Ghai
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Nov 2024 |
250 |
2,516
|
-
|
|
-
|
Common Stock |
Jyotsna Ghai
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
02 Oct 2024 |
1,666 |
2,266
|
-
|
|
-
|
Common Stock |
Jyotsna Ghai
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
02 Oct 2024 |
1,666 |
5,000
|
-
|
|
-
|
Restricted Stock Units |
Andrew Spaventa
|
Director, Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 12.38 per share. |
15 Sep 2024 |
175 |
637
|
-
|
12.4 |
2,167
|
Common Stock |
Andrew Spaventa
|
Director, Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
15 Sep 2024 |
312 |
140,275
|
-
|
|
0
|
Common Stock |
Andrew Spaventa
|
Director, Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
15 Sep 2024 |
312 |
325
|
-
|
|
0
|
Common Stock |
Andrew Spaventa
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Sep 2024 |
487 |
812
|
-
|
|
-
|
Common Stock |
Andrew Spaventa
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Sep 2024 |
487 |
4,860
|
-
|
|
-
|
Restricted Stock Units |
Eli Glezer
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Sep 2024 |
250 |
2,500
|
-
|
|
-
|
Restricted Stock Units |
Eli Glezer
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Sep 2024 |
250 |
154,333
|
-
|
|
-
|
Common Stock |
Dalen Meeter
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Sep 2024 |
209 |
2,083
|
-
|
|
-
|
Restricted Stock Units |
Dalen Meeter
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Sep 2024 |
209 |
8,193
|
-
|
|
-
|
Common Stock |
Andrew Spaventa
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
12 Aug 2024 |
1,906 |
2,231
|
-
|
|
-
|
Common Stock |
Andrew Spaventa
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
12 Aug 2024 |
1,906 |
26,687
|
-
|
|
-
|
Restricted Stock Units |
Andrew Spaventa
|
Director, Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
12 Aug 2024 |
1,225 |
139,963
|
-
|
|
0
|
Common Stock |
Andrew Spaventa
|
Director, Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
12 Aug 2024 |
1,225 |
325
|
-
|
|
0
|
Common Stock |
Andrew Spaventa
|
Director, Chief Executive Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.12 per share. |
12 Aug 2024 |
681 |
1,550
|
-
|
7.1 |
4,849
|
Common Stock |
Eli Glezer
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Aug 2024 |
500 |
154,083
|
-
|
|
-
|
Common Stock |
Eli Glezer
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Aug 2024 |
500 |
7,000
|
-
|
|
-
|
Restricted Stock Units |
Dalen Meeter
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Aug 2024 |
500 |
7,984
|
-
|
|
-
|
Common Stock |
Dalen Meeter
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Aug 2024 |
500 |
7,000
|
-
|
|
-
|
Restricted Stock Units |
Jyotsna Ghai
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Aug 2024 |
250 |
600
|
-
|
|
-
|
Common Stock |
Jyotsna Ghai
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 Aug 2024 |
250 |
3,500
|
-
|
|
-
|
Restricted Stock Units |
Andrew Spaventa
|
Director, Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
15 Jun 2024 |
14,584 |
4,162,144
|
-
|
|
0
|
Common Stock |
Andrew Spaventa
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jun 2024 |
14,584 |
160,416
|
-
|
|
-
|
Restricted Stock Units |
Andrew Spaventa
|
Director, Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
15 Jun 2024 |
14,584 |
9,766
|
-
|
|
0
|
Common Stock |
Andrew Spaventa
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jun 2024 |
14,584 |
24,350
|
-
|
|
-
|
Common Stock |
Eli Glezer
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jun 2024 |
7,500 |
4,607,500
|
-
|
|
-
|
Common Stock |
Eli Glezer
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jun 2024 |
7,500 |
82,500
|
-
|
|
-
|
Restricted Stock Units |
Dalen Meeter
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jun 2024 |
6,250 |
68,750
|
-
|
|
-
|
Restricted Stock Units |
Dalen Meeter
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jun 2024 |
6,250 |
224,523
|
-
|
|
-
|
Common Stock |
David L. Barker
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 May 2024 |
74,000 |
74,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Elaine R. Mardis
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 May 2024 |
74,000 |
74,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael J. Pellini
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 May 2024 |
100,000 |
100,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Jason Ryan
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 May 2024 |
74,000 |
74,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Kim P. Kamdar
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 May 2024 |
74,000 |
74,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Marcia Eisenberg
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 May 2024 |
55,500 |
55,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
Andrew Spaventa
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
12 May 2024 |
57,188 |
857,812
|
-
|
|
-
|
Restricted Stock Units |
Andrew Spaventa
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
12 May 2024 |
57,188 |
66,954
|
-
|
|
-
|
Common Stock |
Andrew Spaventa
|
Director, Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
12 May 2024 |
57,188 |
9,766
|
-
|
|
0
|
Common Stock |
Andrew Spaventa
|
Director, Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
12 May 2024 |
57,188 |
4,147,560
|
-
|
|
0
|
Common Stock |
Eli Glezer
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 May 2024 |
15,000 |
225,000
|
-
|
|
-
|
Restricted Stock Units |
Eli Glezer
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 May 2024 |
15,000 |
4,600,000
|
-
|
|
-
|
Common Stock |
Dalen Meeter
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 May 2024 |
15,000 |
215,273
|
-
|
|
-
|
Common Stock |
Dalen Meeter
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 May 2024 |
15,000 |
225,000
|
-
|
|
-
|
Restricted Stock Units |
Jyotsna Ghai
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 May 2024 |
7,500 |
10,500
|
-
|
|
-
|
Common Stock |
Jyotsna Ghai
|
Chief Operating Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
09 May 2024 |
7,500 |
112,500
|
-
|
|
-
|
Restricted Stock Units |
Andrew Spaventa
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Mar 2024 |
14,583 |
24,349
|
-
|
|
-
|
Common Stock |
Andrew Spaventa
|
Director, Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
15 Mar 2024 |
14,583 |
4,090,372
|
-
|
|
0
|
Common Stock |
Andrew Spaventa
|
Director, Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
15 Mar 2024 |
14,583 |
9,766
|
-
|
|
0
|
Common Stock |
Andrew Spaventa
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Mar 2024 |
14,583 |
175,000
|
-
|
|
-
|
Restricted Stock Units |
Eli Glezer
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Mar 2024 |
7,500 |
90,000
|
-
|
|
-
|
Restricted Stock Units |
Eli Glezer
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Mar 2024 |
7,500 |
4,585,000
|
-
|
|
-
|
Common Stock |
Dalen Meeter
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Mar 2024 |
6,250 |
200,273
|
-
|
|
-
|
Common Stock |
Dalen Meeter
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Mar 2024 |
6,250 |
75,000
|
-
|
|
-
|
Restricted Stock Units |
Samuel Ropp
|
Chief Commercial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Mar 2024 |
4,187 |
50,250
|
-
|
|
-
|
Restricted Stock Units |
Samuel Ropp
|
Chief Commercial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Mar 2024 |
4,187 |
16,750
|
-
|
|
-
|
Common Stock |
Spaventa Andrew
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Feb 2024 |
915,000 |
915,000
|
-
|
|
-
|
Restricted Stock Unit |
Dalen Meeter
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Feb 2024 |
240,000 |
240,000
|
-
|
|
-
|
Restricted Stock Unit |
Jyotsna Ghai
|
Chief Operating Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Feb 2024 |
120,000 |
120,000
|
-
|
|
-
|
Restricted Stock Unit |
Samuel Ropp
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Feb 2024 |
200,000 |
200,000
|
-
|
|
-
|
Restricted Stock Unit |
Eli Glezer
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Feb 2024 |
240,000 |
240,000
|
-
|
|
-
|
Restricted Stock Unit |
Dalen Meeter
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Dec 2023 |
6,250 |
81,250
|
-
|
|
-
|
Restricted Stock Units |
Glezer Eli
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Dec 2023 |
7,500 |
97,500
|
-
|
|
-
|
Restricted Stock Units |
Andrew Spaventa
|
Director, Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
15 Dec 2023 |
14,583 |
4,075,789
|
-
|
|
0
|
Common Stock |
Spaventa Andrew
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Dec 2023 |
14,583 |
189,583
|
-
|
|
-
|
Restricted Stock Units |
Spaventa Andrew
|
Director, Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
15 Dec 2023 |
14,583 |
9,766
|
-
|
|
0
|
Common Stock |
Samuel Ropp
|
Chief Commercial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Dec 2023 |
4,188 |
12,563
|
-
|
|
-
|
Common Stock |
Eli Glezer
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Dec 2023 |
7,500 |
4,577,500
|
-
|
|
-
|
Common Stock |
Spaventa Andrew
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Dec 2023 |
14,583 |
24,349
|
-
|
|
-
|
Common Stock |
Samuel Ropp
|
Chief Commercial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Dec 2023 |
4,188 |
54,437
|
-
|
|
-
|
Restricted Stock Units |
Meeter Dalen
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Dec 2023 |
6,250 |
194,023
|
-
|
|
-
|
Common Stock |
Samuel Ropp
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Aug 2023 |
100,000 |
100,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
Samuel Ropp
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Aug 2023 |
100,000 |
100,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
Kim P. Kamdar
|
Director |
Sale of securities on an exchange or to another person at price $ 0.53 per share. |
11 Aug 2023 |
200,000 |
3,763,985
|
-
|
0.5 |
106,960
|
Common Stock |
Kim P. Kamdar
|
Director |
Sale of securities on an exchange or to another person at price $ 0.57 per share. |
11 Aug 2023 |
77,991 |
3,963,985
|
-
|
0.6 |
44,424
|
Common Stock |
Kim P. Kamdar
|
Director |
Sale of securities on an exchange or to another person at price $ 0.60 per share. |
11 Aug 2023 |
353,657 |
4,041,976
|
-
|
0.6 |
210,603
|
Common Stock |
Marcia Eisenberg
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Aug 2023 |
148,000 |
148,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Andrew Spaventa
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jun 2023 |
14,583 |
218,750
|
-
|
|
-
|
Restricted Stock Units |
Andrew Spaventa
|
Director, Chief Executive Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jun 2023 |
14,583 |
24,349
|
-
|
|
-
|
Common Stock |
Andrew Spaventa
|
Director, Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
15 Jun 2023 |
14,583 |
9,766
|
-
|
|
0
|
Common Stock |
Andrew Spaventa
|
Director, Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
15 Jun 2023 |
14,583 |
3,928,154
|
-
|
|
0
|
Common Stock |
Eli Glezer
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jun 2023 |
7,500 |
4,362,500
|
-
|
|
-
|
Common Stock |
Eli Glezer
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jun 2023 |
7,500 |
112,500
|
-
|
|
-
|
Restricted Stock Units |
Dalen Meeter
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jun 2023 |
6,250 |
93,750
|
-
|
|
-
|
Restricted Stock Units |
Dalen Meeter
|
Chief Financial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jun 2023 |
6,250 |
181,521
|
-
|
|
-
|
Common Stock |
Samuel Ropp
|
Chief Commercial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jun 2023 |
4,188 |
62,812
|
-
|
|
-
|
Restricted Stock Units |
Samuel Ropp
|
Chief Commercial Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
15 Jun 2023 |
4,188 |
4,188
|
-
|
|
-
|
Common Stock |
David L. Barker
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 May 2023 |
74,000 |
74,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Elaine R. Mardis
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 May 2023 |
74,000 |
74,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael J. Pellini
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 May 2023 |
100,000 |
100,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Jason Ryan
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 May 2023 |
74,000 |
74,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Kim P. Kamdar
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
25 May 2023 |
74,000 |
74,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Eli Glezer
|
Chief Scientific Officer |
Purchase of securities on an exchange or from another person at price $ 0.82 per share. |
17 May 2023 |
170,000 |
4,355,000
|
-
|
0.8 |
138,924
|
Common Stock |
Andrew Spaventa
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Mar 2023 |
466,667 |
466,667
|
-
|
|
-
|
Employee Stock Option (right to buy) |
Andrew Spaventa
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Mar 2023 |
233,333 |
233,333
|
-
|
|
-
|
Restricted Stock Unit |
Eli Glezer
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Mar 2023 |
240,000 |
240,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
Eli Glezer
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Mar 2023 |
120,000 |
120,000
|
-
|
|
-
|
Restricted Stock Unit |
Dalen Meeter
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Mar 2023 |
200,000 |
200,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
Dalen Meeter
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Mar 2023 |
100,000 |
100,000
|
-
|
|
-
|
Restricted Stock Unit |
Michael J. Pellini
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
31 Dec 2022 |
72,455 |
26,834
|
-
|
|
0
|
Common Stock |
Andrew Spaventa
|
Director, Chief Executive Officer |
Gift of securities by or to the insider at price $ 0.00 per share. |
31 Dec 2022 |
500,000 |
3,913,571
|
-
|
|
0
|
Common Stock |
Eli Glezer
|
Chief Scientific Officer |
Purchase of securities on an exchange or from another person at price $ 2.00 per share. |
12 Dec 2022 |
50,000 |
4,185,000
|
-
|
2 |
100,000
|
Common Stock |
David L. Barker
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
07 Jul 2022 |
60,000 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
David L. Barker
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.63 per share. |
07 Jul 2022 |
60,000 |
60,000
|
-
|
0.6 |
37,800
|
Common Stock |
Michael J. Pellini
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.21 per share. |
31 May 2022 |
60,668 |
159,957
|
-
|
0.2 |
12,789
|
Common Stock |
Michael J. Pellini
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.24 per share. |
31 May 2022 |
34,271 |
194,228
|
-
|
0.2 |
8,054
|
Common Stock |
Michael J. Pellini
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.63 per share. |
31 May 2022 |
60,000 |
254,228
|
-
|
0.6 |
37,800
|
Common Stock |
Michael J. Pellini
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
31 May 2022 |
154,939 |
99,289
|
-
|
|
0
|
Common Stock |
Michael J. Pellini
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 May 2022 |
60,668 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael J. Pellini
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 May 2022 |
34,271 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael J. Pellini
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
31 May 2022 |
60,000 |
0
|
-
|
|
-
|
Stock Option (Right to Buy) |
David L. Barker
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 May 2022 |
46,250 |
46,250
|
-
|
|
-
|
Stock Option (Right to Buy) |
Elaine R. Mardis
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 May 2022 |
19,271 |
19,271
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael J. Pellini
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 May 2022 |
62,500 |
62,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
Jason Ryan
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 May 2022 |
46,250 |
46,250
|
-
|
|
-
|
Stock Option (Right to Buy) |
Kim P. Kamdar
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 May 2022 |
46,250 |
46,250
|
-
|
|
-
|
Stock Option (Right to Buy) |
Michael J. Pellini
|
Director |
Purchase of securities on an exchange or from another person at price $ 3.30 per share. |
18 May 2022 |
26,834 |
99,289
|
-
|
3.3 |
88,552
|
Common Stock |
Andrew Spaventa
|
Director, Chief Executive Officer |
Other type of transaction at price $ 0.00 per share. |
24 Mar 2022 |
9,766 |
9,766
|
-
|
|
-
|
Common Stock |
Andrew Spaventa
|
Director, Chief Executive Officer |
Other type of transaction at price $ 0.00 per share. |
24 Mar 2022 |
173,144 |
0
|
-
|
|
-
|
Common Stock |
David J. Daly
|
President and Chief Operating |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Mar 2022 |
125,000 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
David J. Daly
|
President and Chief Operating |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Mar 2022 |
125,000 |
0
|
-
|
|
-
|
Employee Stock Option (right to buy) |
Andrew Spaventa
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Mar 2022 |
1,000,000 |
1,000,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
Eli Glezer
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Mar 2022 |
500,000 |
500,000
|
-
|
|
-
|
Employee Stock Option (right to buy) |
Dalen Meeter
|
Senior Vice President, Finance |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Mar 2022 |
187,500 |
187,500
|
-
|
|
-
|
Employee Stock Option (right to buy) |
Elaine R. Mardis
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Jan 2022 |
40,000 |
40,000
|
-
|
|
-
|
Stock Option (Right to Buy) |
Andrew Spaventa
|
Director, Chief Executive Officer |
Other type of transaction at price $ 0.00 per share. |
02 Dec 2021 |
715,884 |
173,144
|
-
|
|
-
|
Common Stock |
Michael J. Pellini
|
Director |
|
01 Jun 2021 |
96,944 |
96,944
|
-
|
|
-
|
Common Stock |
Michael J. Pellini
|
Director |
|
01 Jun 2021 |
96,944 |
0
|
-
|
|
-
|
Series A Preferred Stock |
Kim P. Kamdar
|
Director |
|
01 Jun 2021 |
1,293,243 |
0
|
-
|
|
-
|
Series A Convertible Preferred Stock |
Kim P. Kamdar
|
Director |
|
01 Jun 2021 |
2,666,781 |
0
|
-
|
|
-
|
Series Seed Convertible Preferred Stock |
Kim P. Kamdar
|
Director |
|
01 Jun 2021 |
4,395,633 |
4,495,633
|
-
|
|
-
|
Common Stock |
Kim P. Kamdar
|
Director |
|
01 Jun 2021 |
435,609 |
0
|
-
|
|
-
|
Series B Convertible Preferred Stock |
Andrew Spaventa
|
Director, Chief Executive Officer |
|
01 Jun 2021 |
173,144 |
0
|
-
|
|
-
|
Convertible Promissory Note |
Andrew Spaventa
|
Director, Chief Executive Officer |
|
01 Jun 2021 |
173,144 |
889,028
|
-
|
17.6 |
3,047,334
|
Common Stock |
Andrew Spaventa
|
Director, Chief Executive Officer |
|
01 Jun 2021 |
715,884 |
715,884
|
-
|
|
-
|
Common Stock |
Andrew Spaventa
|
Director, Chief Executive Officer |
|
01 Jun 2021 |
362,266 |
0
|
-
|
|
-
|
Series Seed Preferred Stock |
Andrew Spaventa
|
Director, Chief Executive Officer |
|
01 Jun 2021 |
152,463 |
0
|
-
|
|
-
|
Series B Preferred Stock |
Andrew Spaventa
|
Director, Chief Executive Officer |
|
01 Jun 2021 |
201,155 |
0
|
-
|
|
-
|
Series A Preferred Stock |
Dalen Meeter
|
Senior Vice President, Finance |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 May 2021 |
50,000 |
50,000
|
-
|
|
-
|
Employee Stock Option |